ClC-3 promotes paclitaxel resistance via modulating tubulins polymerization in ovarian cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ClC-3 promotes paclitaxel resistance via modulating tubulins polymerization in ovarian cancer cells

Published:2021-06 Issue: Volume:138 Page:111407
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Feng Jiezhu,Peng Zihan,Gao Lvfen,Yang Xiurou,Sun Zele,Hou Xiuying,Li Enze,Zhu Linyan,Yang Haifeng

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference44 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. Epithelial ovarian cancer;Lheureux;Lancet,2019

3. A. du Bois, M. Quinn, T. Thigpen, J. Vermorken, E. Avall-Lundqvist, M. Bookman, D. Bowtell, M. Brady, A. Casado, A. Cervantes, E. Eisenhauer, M. Friedlaender, K. Fujiwara, S. Grenman, J.P. Guastalla, P. Harper, T. Hogberg, S. Kaye, H. Kitchener, G. Kristensen, R. Mannel, W. Meier, B. Miller, J.P. Neijt, A. Oza, R. Ozols, M. Parmar, S. Pecorelli, J. Pfisterer, A. Poveda, D. Provencher, E. Pujade-Lauraine, M. Randall, J. Rochon, G. Rustin, S. Sagae, F. Stehman, G. Stuart, E. Trimble, P. Vasey, I. Vergote, R. Verheijen, U. Wagner, I. Gynecologic Cancer, O. Ago, Anzgog, Eortc, Geico, Gineco, Gog, Jgog, Mrc/Ncri, C.T.G. Ncic, U.S. Nci, Nsgo, Rtog, Sgctg, Igcs, O. Organizational team of the two prior International, 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004), Annals of oncology: official journal of the European Society for Medical Oncology 16 (Suppl 8) 2005, viii7–viii12.

4. Front-line therapy of advanced epithelial ovarian cancer: standard treatment;Marth;Ann. Oncol. Off. J. Eur. Soc. Med. Oncol.,2017

5. Mechanism of action of taxol;Horwitz;Trends Pharmacol. Sci.,1992

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy;Autoimmunity Reviews;2024-06

2. CLCN3 in mediating the proliferation of human ovarian cancer cells;Translational Cancer Research;2024-03

3. Resensitizing Paclitaxel-Resistant Ovarian Cancer via Targeting Lipid Metabolism Key Enzymes CPT1A, SCD and FASN;International Journal of Molecular Sciences;2023-11-19

4. Physiological roles of chloride ions in bodily and cellular functions;The Journal of Physiological Sciences;2023-11-15

5. Efficacy and Safety of Paclitaxel and Carboplatin for Platinum-Sensitive Ovarian Cancer: A Systematic Review and Meta-Analysis;Journal of Clinical Pharmacy and Therapeutics;2023-06-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3